ReviewViruses2024
A Concise Overview of Studies on Successful Real-World Applications of Bacteriophages in Aquaculture.
Review in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bacteriophages AgainstViruses · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Increasing antibiotic resistance poses an urgent global public health threat and a serious concern worldwide. Bacteriophage (phage) therapy has been identified as a promising alternative to antibiotics for treating bacterial diseases in both humans and animals. The excessive use of antibiotics in aquaculture is a major threat to sustainable aquaculture, promoting the spread of antibiotic resistance in the aquaculture environment and the contamination of aquaculture products with antibiotic residues. Consequently, interest in alternative approaches that reduce reliance on antibiotics has grown within the aquaculture sector. As a promising alternative, extensive phage research targeted at aquaculture has demonstrated the protective efficacy of phages against diseases in aquatic animals. Although numerous studies have employed in vitro models, research supported by in vivo experiments remains scarce. Without in vivo evidence, phage therapy cannot fulfill the requirements of aquaculturists. The first part of this review outlines the bacterial diseases severely affecting the health and survival of aquatic animals. The second part provides updates on phage applications for the therapy and prophylaxis of pathogenic bacterial infection in aquatic animals, including administration routes and key accomplishments. Therefore, this review provides insights into effective real-world phage biocontrol strategies that enable sustainable aquaculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.